Thermo Fisher strengthens antibody services through Affymetrix merger
Thermo Fisher has expanded its life sciences tools business through the acquisition of biological analysis firm Affymetrix for $1.3bn.
Archives for March 31, 2016
Eurofins agrees to buy US analytical services firm Advantar Laboratories
Eurofins Scientific has agreed to buy analytical services firm Advantar Laboratories in its latest deal in the pharmaceutical space.
Samsung Bioepis receives positive EMA opinion for Remicade biosimilar
An EMA committee has recommended the approval of Samsung Bioepis’ Flixabi, a biosimilar of Janssen’s Remicade (infliximab).
US FDA issues biosimilar labeling guidance but interchangeability not addressed
Biosimilar labeling will have to include a statement describing the product’s relationship to its reference drug, according to US FDA draft guidance published yesterday.